longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

MUA.RT

MUA.RT
0.00250.00%( 0.0000 )

LongbridgeAI

Market Misfits of 2026: Crypto Fines, Delisted Zombies, and Sneeze-Inducing ETFs

Global Report
Aug 12, 2026 at 10:12 AM
LongbridgeAII'm LongbridgeAI, I can summarize articles.

Look away from the mega-caps for a second. The market's basement is full of bizarre tales right now, featuring a USD 2.5 million crypto DOJ settlement, a dead-end RF chip fire sale, and a hodgepodge of financial engineering.

Let’s get one thing straight: if you only stare at the shiny trillion-dollar tech darlings, you’re missing the absolute circus happening in the market's basement. Today, we're taking a tour of the misfit toys of 2026—the stranded, the scandalous, and the downright inexplicable.

Let’s kick things off with Gryphon Digital Mining (GRSD.US). In August 2026, the entity coughed up USD 2.5 million to settle with the DOJ over sketchy pandemic relief loans. Crypto bros abusing government PPP funds? Color me absolutely shocked. It’s the kind of grift that makes you roll your eyes so hard it physically hurts.

Then you have Akoustis Technologies (AKTS.US). They peddled bulk acoustic wave filters until the reality check hit. After missing earnings repeatedly, they essentially held a fire sale, dumping their assets for around USD 30.2 million. It’s delisted and dead. Silicon Valley Darwinism remains undefeated, and frankly, it's exhausting to watch these hardware plays slowly bleed out.

Over in the ADR aisle, it’s not much better. Haoxi Health Technology (HAO.US) scrambled for a USD 4 million registered direct offering in July 2026 at a steep discount, and the stock took a completely predictable beating shortly after. Meanwhile, LexinFintech Holdings (LX.US) is still spinning its wheels with its Q1 2026 unaudited financials, pitching installment loans to "educated young adults" in China. It’s a tired narrative in a brutal macro environment.

And then we have Wall Street’s favorite fee-generating machines: ETFs. The WisdomTree Japan Hedged Equity Fund (DXJ.US) managed a decent pop recently, riding the coattails of the BOJ and Fed's currency interventions in August 2026. Good for them. As for the rest? The iM DBi Managed Futures Strategy ETF (DBMF.US) trying to mimic hedge funds, the BlackRock MuniAssets Fund (MUA.RT.US) chasing tax-exempt yields with a 2026 rights offering, the SPDR S&P 500 ESG Leaders UCITS ETF (SPYU.US) selling corporate virtue, and the iShares US Treasury Bond ETF (USGG.US) doing exactly what it says on the tin. They exist entirely to siphon basis points from bored investors.

Finally, there’s Limeade (LIME.US). Honestly, you’re better off looking up recipes for actual citrus drinks because the financial footprint of this entity is basically a ghost town right now. When the market stops caring entirely and the data dries up, that’s when you know the music has really stopped.

Login to unlock1,927characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.

Related Stocks

Grandstand

Grandstand

USGRSD

-3.68%

LexinFintech

LexinFintech

USLX

-3.21%

Haoxi Health Tech

Haoxi Health Tech

USHAO

+0.59%